Patrick Zweidler-McKay

Patrick Zweidler-McKay

Company: ImmunoGen

Job title: Executive Medical Director


Sharing Results from SORAYA: A Phase III Trial of Mirvetuximab soravtansine in Platinum Resistant, FRα-high Ovarian Cancer 3:30 pm

Discussing efficacy and safety of MIRV in FR-alpha high, platinum resistant ovarian cancer Outlining the evolution of the companion diagnostics and impacts on trials Sharing information about on-going trials and next stepsRead more

day: day 2- pm

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.